Latest information on COVID-19
Support teaching, research, and patient care.
We are studying the effects of ICU-trained RNs and MDs on outcomes for critically ill patients in the Emergency Department.
Stanford University Hospital
Stanford, CA
Emergency critical care & resuscitation, ARDS, sepsis
Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE Recruiting
This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic and additional strategies for prevention of adverse outcomes in COVID-19 positive inpatients
View full details
ACTIV-3: Therapeutics for Inpatients With COVID-19 Recruiting
This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either a study drug plus current standard of care (SOC), or with placebo plus current SOC.
ARrest RESpiraTory Failure From PNEUMONIA Recruiting
This research study seeks to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis Recruiting
Multicenter, prospective, phase 3 randomized non-blinded interventional trial of fluid treatment strategies in the first 24 hours for patients with sepsis-induced hypotension. The aim of the study is to determine the impact of a restrictive fluids strategy (vasopressors first followed by rescue fluids) as compared to a liberal fluid strategy (fluids first followed by rescue vasopressors) on 90-day in-hospital mortality in patients with sepsis-induced hypotension.
